Differential infectivity and division of Toxoplasma gondii in human peripheral blood leukocytes

Infection and Immunity

Volumn 68, Issue 8, 2000, Pages 4822-4826

  Channon, Jacqueline Y ^a,b   Seguin, Rosanne M ^a,c   Kasper, Lloyd H ^a  

^a DARTMOUTH MEDICAL SCHOOL   (United States)

^b DHMC ^*  (United States)

^c MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CELL DIVISION; DENDRITIC CELL; HUMAN; HUMAN CELL; LEUKOCYTE; LYMPHOCYTE; MONOCYTE; NEUTROPHIL; PRIORITY JOURNAL; TOXOPLASMA GONDII; TOXOPLASMOSIS;

ANIMALS; CELL DIVISION; DENDRITIC CELLS; FIBROBLASTS; HUMANS; LEUKOCYTES; LYMPHOCYTES; MONOCYTES; NEUTROPHILS; TOXOPLASMA;

EID: 0033943813     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.68.8.4822-4826.2000     Document Type: Article

References (33)

1. Anderson, S. E., S. Bautista, and J. S. Remington. 1976. Induction of resistance to Toxoplasma gondii in human macrophages by soluble lymphocyte products. J. Immunol. 117:381-387.
2. Channon, J. Y., and L. H. Kasper. 1996. Toxoplasma gondii-induced immune suppression by human peripheral blood monocytes: role of gamma interferon. Infect. Immun. 64:1181-1189.
3. Channon, J. Y., E. I. Suh, R. M. Seguin, and L. H. Kasper. 1999. Attachment ligands of viable Toxoplasma gondii induce soluble immunosuppressive factors in human monocytes. Infect. Immun. 67:2547-2551.
4. Chao, C. C., R. G. Gekke, S. Hu, and P. K. Peterson. 1994. Human microglial cell defense against Toxoplasma gondii. The role of cytokines. J. Immunol. 152:1246-1252.
5. Delemarre, F. G., A. Stevenhagen, F. P. Kroon, M. Y. Van Eer, P. L. Meenhorst, and R. Van Furth. 1994. Effect of IFN-gamma on the proliferation of Toxoplasma gondii in monocytes and monocyte-derived macrophages from AIDS patients. Immunology 83:646-650.
6. Denney, C. F., L. Eckmann, and S. L. Reed. 1999. Chemokine secretion of human cells in response to Toxoplasma gondii infection. Infect. Immun. 67:1547-1552.
7. Dobrowolski, J. M., and L. D. Sibley. 1996. Toxoplasma invasion of mammalian cells is powered by the actin cytoskeleton of the parasite. Cell 84: 933-939.
8. S. Erbe, D. V., E. R. Pfefferkorn, and M. W. Fanger. 1991 Functions of the various IgG Fc receptors in mediating killing of Toxoplasma gondii. J. Immunol. 146:3145-3151.
9. Fadul, C. E., J. Y. Channon, and L. H. Kasper. 1995. Survival of immunoglobulin G-opsonized Toxoplasma gondii in nonadherent human monocytes. Infect. Immun. 63:4290-4294.
10. Halonen, S. K., W. D. Lyman, and F. C. Chiu. 1996. Growth and development of Toxoplasma gondii in human neurons and astrocytes. J. Neuropathol. Exp. Neurol. 55:1150-1156.
11. Haynes, B. F., and A. S. Fauci. 1998. Introduction to the immune system, p. 1753-1776. In A. Fauci, E. Braunwald, K. Isselbacher, J. Wilson, J. Martin, D. Kasper, S. Hauser, and D. Longo (ed.), Harrison's principles of internal medicine, 14th ed. McGraw-Hill, New York, N.Y.
12. Jebbari, H., C. W. Roberts, D. J. Ferguson, H. Bluethmann, and J. Alexander. 1999. A protective role for IL-6 during early infection with Toxoplasma gondii. Parasite Immunol. 20:231-239.
13. Kasper, L. H. 1998. Toxoplasma infection, p. 1197-1202. In A. Fauci, E. Braunwald, K. Isselbacher, J. Wilson, J. Martin, D. Kasper, S. Hauser, and D. Longo (ed.), Harrison's principles of internal medicine, 14th ed. McGraw-Hill, New York, N.Y.
14. Locksley, R. M., C. S. Nelson, J. E. Fankhauser, and S. J. Klebanoff. 1987. Loss of granule myeloperoxidase during in vitro culture of human monocytes correlates with decay in antiprotozoa activity. Am. J. Trop. Med. Hyg. 36: 541-548.
15. McLeod, R., K. G. Bensch, S. M. Smith, and J. S. Remington. 1980. Effects of human peripheral blood monocytes, monocyte-derived macrophages, and spleen mononuclear phagocytes on Toxoplasma gondii. Cell. Immunol. 54: 330-350.
16. Murray, H. W., B. Y. Rubin, S. M. Carriero, A. M. Harris, and E. A. Jaffee. 1985. Human mononuclear phagocyte antiprotozoal mechanisms: oxygen-dependent vs oxygen-independent activity against intracellular Toxoplasma gondii. J. Immunol. 134:1982-1988.
17. Murray, H. W., A. Szuro-Sudol, D. Wellner, M. J. Oca, A. M. Granger, D. M. Libby, C. D. Rothermel, and B. Y. Rubin. 1989. Role of tryptophan degradation in respiratory burst-independent antimicrobial activity of gamma interferon-stimulated human macrophages. Infect. Immun. 57:845-849.
18. Nagineni, C. N., K. Pardhasaradhi, M. C. Martins, B. Detrick, and J. J. Hooks. 1996. Mechanisms of interferon-induced inhibition of Toxoplasma gondii replication in human retinal pigment epithelial cells. Infect. Immun. 64:4188-4196.
19. Nakao, M., and E. Konishi. 1991. Proliferation of Toxoplasma gondii in human neutrophils in vitro. Parasitology 103:23-27.
20. Peterson, P. K., G. Gekker, S. Hu, and C. C. Chao. 1995. Human astrocytes inhibit intracellular multiplication of Toxoplasma gondii by a nitric oxide-mediated mechanism. J. Infect. Dis. 171:516-518.
21. Pfefferkorn, E. R. 1990. Cell biology of Toxoplasma gondii, p. 26-50. In D. J. Wyler (ed.), Modern parasite biology. Cellular, immunological, and molecular aspects. W. H. Freeman & Co., New York, N.Y.
22. Pfefferkorn, E. R. 1984. Interferon-gamma blocks the growth of Toxoplasma gondii in human fibroblasts by inducing the host cells to degrade tryptophan. Proc. Natl. Acad. Sci. USA 81:908-912.
23. Pfefferkorn, E. R., and P. M. Guyre. 1984. Inhibition of growth of Toxoplasma gondii in cultured fibroblasts by human recombinant gamma interferon. Infect. Immun. 44:211-216.
24. Pfefferkorn, E. R., and L. C. Pfefferkorn. 1976. Toxoplasma gondii: isolation and preliminary characterization of temperature-sensitive mutants. Exp. Parasitol. 39:365-376.
25. Sayles, P., and L. Johnson. 1996-1997. Exacerbation of toxoplasmosis in neutrophil-depleted mice. Nat. Immun. 15:249-258.
26. Scharton-Kersten, T. M., G. Yap, J. Magram, and A. Sher. 1997. Inducible nitric oxide is essential for host control of persistent but not acute infection with the intracellular pathogen Toxoplasma gondii. J. Exp. Med. 185:1261-1273.
27. Seguin, R. M., and L. H. Kasper. 1999. Sensitized lymphocytes and CD40 ligation augment interleukin-12 production by human dendritic cells in response to Toxoplasma gondii. J. Infect. Dis. 179:467-474.
28. Sibley, L. D., E. Weidner, and J. L. Krahenbuhl. 1985. Phagosome acidification blocked by intracellular Toxoplasma gondii. Nature 315:416-419.
29. Suzuki, Y., M. A. Orellana, R. D. Schreiber, and J. S. Remington. 1988. Interferon-γ: the major mediator of resistance against Toxoplasma gondii. Science 240:516-518.
30. Wilson, C. B., and J. S. Remington. 1979. Activity of human blood leukocytes against Toxoplasma gondii. J. Infect. Dis. 140:890-895.
31. Wilson, C. B., and J. Westall. 1985. Activation of neonatal and human macrophages by alpha, beta, and gamma interferons. Infect. Immun. 49:351-356.
32. Woodman, J. P., I. H. Dimier, and D. T. Bout. 1991. Human endothelial cells are activated by IFN-γ to inhibit Toxoplasma gondii replication. Inhibition is due to a different mechanism from that existing in mouse macrophages and human fibroblasts. J. Immunol. 147:2019-2023.
33. Yap, G. S., and A. Sher. 1999. Effector cells of both nonhemopoietic and hemopoietic origin are required for interferon (IFN)-gamma- and tumor necrosis factor (TNF)-alpha-dependent host resistance to the intracellular pathogen, Toxoplasma gondii. J. Exp. Med. 189:1083-1092.